Important aspects of T‐cell collection by apheresis for manufacturing chimeric antigen receptor T cells-Reference-Cited by-同舟云学术

Important aspects of T‐cell collection by apheresis for manufacturing chimeric antigen receptor T cells

Published:2019-10-13 Issue:1 Volume:3 Page:
ISSN:2573-8461
Container-title:ADVANCES IN CELL AND GENE THERAPY
language:en
Short-container-title:Adv Cell Gene Ther

Author:

Paroder Monika¹,Le Nguyet²,Pham Huy P.³,Thibodeaux Suzanne R.⁴^ORCID

Affiliation:

1. Department of Pathology Montefiore Medical Center of the Albert Einstein College of Medicine Bronx NY USA

2. Department of Pathology Indiana University School of Medicine Indianapolis IN USA

3. Department of Pathology Keck School of Medicine of the University of Southern California Los Angeles CA USA

4. Department of Pathology and Immunology Washington University in St. Louis School of Medicine St. Louis MO USA

Publisher

Hindawi Limited

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acg2.75

Reference58 articles.

1. Engineered T cells: the promise and challenges of cancer immunotherapy

2. CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

3. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

4. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

5. Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biotechnology Advances in Disease Treatment;International Encyclopedia of Public Health;2025

2. Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtable;Clinical Lymphoma Myeloma and Leukemia;2024-05

3. The Science of CAR ‐T Cell Technology;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

4. Cellular Therapies for Cancer: Chimeric Antigen Receptor T Cells (CAR-T);The Basics of Cancer Immunotherapy;2024

5. Managing leukapheresis in adult and pediatric patients eligible for chimeric antigen receptor T-cell therapy: suggestions from an Italian Expert Panel;BLOOD TRANSFUS-ITALY;2023